Enhanced Sensitivity and Human Relevance: a TNF‐α‐Induced HaCaT Keratinocyte Model for Screening Anti‐Inflammatory Cosmetic Materials
Journal of Applied Toxicology · 2026
DOI: 10.1002/jat.70120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2026. Verfasst von Weizuo Liao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Food Safety and Health Research Center, NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong-Hongkong-Macao Joint Laboratory for Contami…. Hauptthemen laut MEDLINE: Keratinocytes, Tumor Necrosis Factor-alpha, Anti-Inflammatory Agents, Cosmetics. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Scientific Instrument and Equipment Development Projects of China during the 14th Five-year Plan Period, Basic and Applied Basic Research Foundation of Guangdong Province, GDMPA Project of Scientific and Technological Innovation.
Abstract (Originalsprache)
A TNF‐α‐induced inflammatory model using the human keratinocyte HaCaT cell line was developed and validated as an alternative in vitro method for evaluating the anti‐inflammatory potential of cosmetic ingredients. In comparison with the conventional lipopolysaccharide (LPS)–stimulated RAW264.7 murine macrophage model, the HaCaT‐based system demonstrated enhanced sensitivity, detecting significant cytokine inhibition at concentrations up to 1000‐fold lower for certain actives. The model reliably distinguished established anti‐inflammatory agents (ectoine, troxerutin, and dipotassium glycyrrhizinate) from non‐active controls (glycerin, butanediol, and propylene glycol) through the suppression of interleukin‐6 (IL‐6). Notably, the HaCaT model also identified a potential pro‐inflammatory shift at high concentrations of some active ingredients—an effect not observed in the RAW264.7 system. Multi‐laboratory verification using the novel cosmetic ingredient β‐nicotinamide mononucleotide (NMN) confirmed both the anti‐inflammatory activity of NMN and the high reproducibility of the assay. These results support the TNF‐α‐HaCaT model as a sensitive, human‐relevant, and reproducible alternative for screening cosmetic ingredients, contributing to the growing toolbox of nonanimal methods for safety and efficacy assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Food Safety and Health Research Center, NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong-Hongkong-Macao Joint Laboratory for Contaminants Exposure and Health, Guangdong Provincial Key Laboratory of Trop…
- Guangdong Bawei Biotechnology Corporation, Guangzhou, China.
- Guangdong Youzhi Testing Technology Corporation, Guangzhou, China.
ORCID-Profile: Yuxuan Xiao, Junfeng Deng
Förderung
- National Key Scientific Instrument and Equipment Development Projects of China during the 14th Five-year Plan Period
- Basic and Applied Basic Research Foundation of Guangdong Province
- GDMPA Project of Scientific and Technological Innovation
Zitieren
APA
Liao, W., Xiao, Y., Leng, Q., Yin, X., Li, Z., Deng, J., Zheng, S., Liu, R., Chen, B., Li, S., Niu, Q., Yang, X., & He, Z. (2026). Enhanced Sensitivity and Human Relevance: a TNF‐α‐Induced HaCaT Keratinocyte Model for Screening Anti‐Inflammatory Cosmetic Materials. Journal of Applied Toxicology. https://doi.org/10.1002/jat.70120
Vancouver
Liao W, Xiao Y, Leng Q, Yin X, Li Z, Deng J, et al. Enhanced Sensitivity and Human Relevance: a TNF‐α‐Induced HaCaT Keratinocyte Model for Screening Anti‐Inflammatory Cosmetic Materials. Journal of Applied Toxicology. 2026. doi:10.1002/jat.70120
BibTeX
@article{Liao2026,
author = {Liao, Weizuo and Xiao, Yuxuan and Leng, Qunying and Yin, Xinxin and Li, Ziyin and Deng, Junfeng and Zheng, Shixiong and Liu, Ruixue and Chen, Biao and Li, Shiwei and Niu, Qiang and Yang, Xingfen and He, Zhini},
title = {Enhanced Sensitivity and Human Relevance: a TNF‐α‐Induced HaCaT Keratinocyte Model for Screening Anti‐Inflammatory Cosmetic Materials},
journal = {Journal of Applied Toxicology},
year = {2026},
doi = {10.1002/jat.70120}
}
EUVIMED